Similar articles

• [HLA-restricted cancer-specific killer T cells].

  Harada M, Itoh K. Harada M, et al. Nihon Rinsho. 2005 Apr;63 Suppl 4:579-84. Nihon Rinsho. 2005. PMID: 15861714 Review. Japanese. No abstract available.
• Tumor resistance to CD8+ T cell-based therapeutic vaccination.

  Huang Y, Shah S, Qiao L. Huang Y, et al. Arch Immunol Ther Exp (Warsz). 2007 Jul-Aug;55(4):205-17. doi: 10.1007/s00005-007-0029-3. Epub 2007 Jul 23. Arch Immunol Ther Exp (Warsz). 2007. PMID: 17659376 Review.
• Message in a bottle: role of the 70-kDa heat shock protein family in anti-tumor immunity.

  Calderwood SK, Theriault JR, Gong J. Calderwood SK, et al. Eur J Immunol. 2005 Sep;35(9):2518-27. doi: 10.1002/eji.200535002. Eur J Immunol. 2005. PMID: 16144035 Review.
• [Tumor specific antigen and cytotoxic T lymphocytes].

  Uenaka A, Nakayama E. Uenaka A, et al. Nihon Rinsho. 2005 Apr;63 Suppl 4:568-73. Nihon Rinsho. 2005. PMID: 15861712 Review. Japanese. No abstract available.
• Absence of antitumor natural killer cell-mediated defense in the brain.

  Yamasaki T. Yamasaki T. Surg Neurol. 2004 Mar;61(3):227-8. doi: 10.1016/j.surneu.2003.07.011. Surg Neurol. 2004. PMID: 14984990 No abstract available.